Clinical Trial Update: Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas [Phase 1]

View source ↗

Summary

A Phase 1 trial assessed arsenic trioxide combined with radiation therapy in children with newly diagnosed gliomas. The study has completed the Phase 1 portion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Trisenox (arsenic trioxide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED